MK0457

VX-680 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MK0457, covering 2015-06-17 to 2015-07-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIA Study of MK0457 in Patients With Cancer of the Lung (0457-006) [Phase 2]